0

    506919

    MAKERSL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MAKERS LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month 5.89% Over 3 Months 0.56% Over 6 Months 15.47% Over 1 Year 2.15%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MAKERS LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 93.80
    • P/E Ratio (TTM) -54.62
    • Beta 0.90
    • Book Value / share 92.25
    • Return on equity -3.11%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -1.08
    info icon alternate text

    MAKERS LABORATORIES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 10.19
    Operating Expense 11.52
    Net Profit -1.08
    Net Profit Margin (%) -10.59
    Earnings Per Share (EPS) -1.82
    EBITDA -0.43
    Effective Tax Rate (%) 14.28
    Particulars MAR 2026 (Values in Cr)
    Revenue 11.27
    Operating Expense 12.45
    Net Profit -0.96
    Net Profit Margin (%) -8.51
    Earnings Per Share (EPS) -1.63
    EBITDA -0.35
    Effective Tax Rate (%) 17.24
    Particulars DEC 2025 (Values in Cr)
    Revenue 12.70
    Operating Expense 12.85
    Net Profit -0.17
    Net Profit Margin (%) -1.33
    Earnings Per Share (EPS) -0.29
    EBITDA 0.72
    Effective Tax Rate (%) -21.42
    Particulars SEP 2025 (Values in Cr)
    Revenue 12.64
    Operating Expense 13.57
    Net Profit -0.31
    Net Profit Margin (%) -2.45
    Earnings Per Share (EPS) -0.53
    EBITDA 0.44
    Effective Tax Rate (%) 24.39
    Particulars JUN 2025 (Values in Cr)
    Revenue 13.73
    Operating Expense 14.06
    Net Profit -0.27
    Net Profit Margin (%) -1.96
    Earnings Per Share (EPS) -0.46
    EBITDA 0.50
    Effective Tax Rate (%) 10.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 50.35
    Operating Expense 52.95
    Net Profit -1.72
    Net Profit Margin (%) -3.41
    Earnings Per Share (EPS) -2.91
    EBITDA 1.32
    Effective Tax Rate (%) 14.42
    Particulars MAR 2025 (Values in Cr)
    Revenue 42.94
    Operating Expense 48.94
    Net Profit 4.64
    Net Profit Margin (%) 10.80
    Earnings Per Share (EPS) 7.87
    EBITDA 8.71
    Effective Tax Rate (%) 5.88
    Particulars MAR 2024 (Values in Cr)
    Revenue 49.09
    Operating Expense 57.19
    Net Profit -6.95
    Net Profit Margin (%) -14.15
    Earnings Per Share (EPS) -11.78
    EBITDA -2.62
    Effective Tax Rate (%) 0.14
    Particulars MAR 2023 (Values in Cr)
    Revenue 42.55
    Operating Expense 50.46
    Net Profit -6.36
    Net Profit Margin (%) -14.94
    Earnings Per Share (EPS) -10.58
    EBITDA -3.00
    Effective Tax Rate (%) 6.04
    Particulars MAR 2022 (Values in Cr)
    Revenue 52.38
    Operating Expense 52.92
    Net Profit 0.17
    Net Profit Margin (%) 0.32
    Earnings Per Share (EPS) 0.35
    EBITDA 3.90
    Effective Tax Rate (%) 45.16
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 123.59
    ROE % 10.96
    ROCE % 14.94
    Total Debt to Total Equity 0.12
    EBITDA Margin 11.76
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 119.49
    ROE % -0.36
    ROCE % 6.43
    Total Debt to Total Equity 0.22
    EBITDA Margin 8.36
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 106.85
    ROE % -7.27
    ROCE % -2.19
    Total Debt to Total Equity 0.29
    EBITDA Margin 2.54
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 117.28
    ROE % -3.40
    ROCE % 1.60
    Total Debt to Total Equity 0.31
    EBITDA Margin 5.53
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 121.17
    ROE % 20.61
    ROCE % 22.06
    Total Debt to Total Equity 0.38
    EBITDA Margin 16.86
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 92.25
    ROE % -3.11
    ROCE % -2.54
    Total Debt to Total Equity 0.05
    EBITDA Margin 2.62
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 95.04
    ROE % -10.69
    ROCE % -6.71
    Total Debt to Total Equity 0.16
    EBITDA Margin -3.21
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 87.19
    ROE % -12.67
    ROCE % -7.69
    Total Debt to Total Equity 0.24
    EBITDA Margin -5.32
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 98.78
    ROE % -11.71
    ROCE % -7.67
    Total Debt to Total Equity 0.28
    EBITDA Margin -7.05
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 102.30
    ROE % 0.42
    ROCE % 3.01
    Total Debt to Total Equity 0.35
    EBITDA Margin 7.54
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 0.62
    Total Assets 166.61
    Total Liabilities 166.61
    Total Equity 122.47
    Share Outstanding 0
    Price to Book Ratio 1.47
    Return on Assets (%) 1.41
    Return on Capital (%) 1.85
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.64
    Total Assets 147.94
    Total Liabilities 147.94
    Total Equity 115.19
    Share Outstanding 0
    Price to Book Ratio 1.36
    Return on Assets (%) 5.06
    Return on Capital (%) 6.32
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.23
    Total Assets 161.25
    Total Liabilities 161.25
    Total Equity 104.33
    Share Outstanding 0
    Price to Book Ratio 1.29
    Return on Assets (%) -3.88
    Return on Capital (%) -5.13
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 4.36
    Total Assets 152.29
    Total Liabilities 152.29
    Total Equity 109.67
    Share Outstanding 0
    Price to Book Ratio 0.99
    Return on Assets (%) -3.11
    Return on Capital (%) -3.92
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.67
    Total Assets 144.33
    Total Liabilities 144.33
    Total Equity 98.09
    Share Outstanding 0
    Price to Book Ratio 1.78
    Return on Assets (%) 3.44
    Return on Capital (%) 4.32
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 73.53
    Total Liabilities 73.53
    Total Equity 54.43
    Share Outstanding 0
    Price to Book Ratio 1.47
    Return on Assets (%) -2.33
    Return on Capital (%) -3.01
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 71.39
    Total Liabilities 71.39
    Total Equity 56.07
    Share Outstanding 0
    Price to Book Ratio 1.36
    Return on Assets (%) 6.50
    Return on Capital (%) 8.23
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.07
    Total Assets 86.14
    Total Liabilities 86.14
    Total Equity 51.44
    Share Outstanding 0
    Price to Book Ratio 1.29
    Return on Assets (%) -8.06
    Return on Capital (%) -10.69
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.07
    Total Assets 84.79
    Total Liabilities 84.79
    Total Equity 58.28
    Share Outstanding 0
    Price to Book Ratio 0.99
    Return on Assets (%) -7.50
    Return on Capital (%) -9.42
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 85.48
    Total Liabilities 85.48
    Total Equity 50.30
    Share Outstanding 0
    Price to Book Ratio 1.78
    Return on Assets (%) 0.20
    Return on Capital (%) 0.25
    Particulars MAR 2026 (Values in Cr)
    Net Income 11.14
    Cash from Operations 17.60
    Cash from Investing -14.68
    Cash from Financing 0.35
    Net change in Cash -0.04
    Free Cash Flow 21.31
    Particulars MAR 2025 (Values in Cr)
    Net Income 13.41
    Cash from Operations -1.67
    Cash from Investing 19.74
    Cash from Financing -15.83
    Net change in Cash -0.17
    Free Cash Flow 2.26
    Particulars MAR 2024 (Values in Cr)
    Net Income -3.91
    Cash from Operations 2.61
    Cash from Investing -6.88
    Cash from Financing 5.73
    Net change in Cash -0.30
    Free Cash Flow 9.23
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.83
    Cash from Operations -6.15
    Cash from Investing 1.25
    Cash from Financing 5.78
    Net change in Cash -1.58
    Free Cash Flow 6.75
    Particulars MAR 2022 (Values in Cr)
    Net Income 15.68
    Cash from Operations 24.13
    Cash from Investing -21.79
    Cash from Financing 0.32
    Net change in Cash -2.96
    Free Cash Flow 34.01
    Particulars MAR 2026 (Values in Cr)
    Net Income -2.01
    Cash from Operations -1.42
    Cash from Investing 0.27
    Cash from Financing 1.74
    Net change in Cash 0.00
    Free Cash Flow -1.11
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.92
    Cash from Operations -1.14
    Cash from Investing 16.13
    Cash from Financing -14.55
    Net change in Cash 0.00
    Free Cash Flow 1.27
    Particulars MAR 2024 (Values in Cr)
    Net Income -6.95
    Cash from Operations -2.74
    Cash from Investing -2.03
    Cash from Financing 5.11
    Net change in Cash 0.01
    Free Cash Flow -0.04
    Particulars MAR 2023 (Values in Cr)
    Net Income -6.77
    Cash from Operations -1.02
    Cash from Investing -3.55
    Cash from Financing 4.93
    Net change in Cash -0.03
    Free Cash Flow 3.45
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.31
    Cash from Operations 7.35
    Cash from Investing -8.78
    Cash from Financing 1.76
    Net change in Cash -0.20
    Free Cash Flow 18.44
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD. 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LTD. 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTAJAN HEALTH LTD 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 477.10 51.63 4.38 5068.90 118.35 552.90

    MAKERS LABORATORIES LTD. shareholding pattern

    Holding
    38.33%
    61.27%
    0.38%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MAKERS LABORATORIES LTD. Technicals Summary

    158.95 -4.18 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 159.70
    • 26 Days 154.10
    • 10 Days 157.20
    • 50 Days 152.80
    • 12 Days 156.50
    • 100 Days 150.30
    • 20 Days 154.80
    • 200 Days 147.00
    166.82 PIVOT
    First Support 162.88 First Resistance 169.83 Second Support 159.87 Second Resistance 173.77 Third Support 155.93 Third Resistance 176.78
    RSI 55.50 ADX 38.20 MACD 2.43 Williams % R -61.60 Commodity Channel Index (CCI) 170.63
    Date 2026-08-07 Week 11553.00 Same Day 27387.00 Month 3909.00
    1 Year 0.91 3 Year 0.55
    Over 1 Month
    5.89% down
    Over 1 Year
    2.15% down
    Over 3 Months
    0.56% down
    Over 3 Years
    11.91% down
    Over 6 Months
    15.47% down
    Over 5 Years
    -4.23% down

    MAKERS LABORATORIES LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    01 Aug 2019 1.0 Final 03 Aug 2019 Equity shares
    26 Jul 2018 1.0 Final 28 Jul 2018 Equity shares
    20 Jul 2017 1.0 Final 22 Jul 2017 Equity shares
    02 Aug 2016 1.0 Final 04 Aug 2016 Equity shares
    28 Jul 2015 1.0 Final 30 Jul 2015 Equity shares
    29 Jul 2011 1.0 Final 02 Aug 2011 Equity shares
    17 Aug 2010 1.0 Final 19 Aug 2010 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Makers Laboratories Ltd?

    Answer Field

    Makers Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 158.95 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of Makers Laboratories Ltd Share?

    Answer Field

    The market cap of Makers Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 93.80 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of Makers Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Makers Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 186.70 and ₹ 109.00.

    What is 1 year return for Makers Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been 2.15%.

    What is the P/E Ratio of Makers Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for Makers Laboratories Ltd share is -54.62.

    What is the PB ratio of Makers Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for Makers Laboratories Ltd share is 92.25.

    How to Buy Makers Laboratories Ltd Share?

    Answer Field

    You can trade in Makers Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Makers Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Makers Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Makers Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |